Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Folic acid supplementation during methotrexate treatment: nonsense?
Manna R, Verrecchia E, Diaco M, Montalto M, Cammarota G, Gasbarrini G. Manna R, et al. Rheumatology (Oxford). 2005 Apr;44(4):563-4. doi: 10.1093/rheumatology/keh541. Epub 2005 Jan 18. Rheumatology (Oxford). 2005. PMID: 15657069 No abstract available.
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study.
Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, Gentileschi S, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Rigante D, Cantarini L. Vitale A, et al. Among authors: manna r. Front Pharmacol. 2016 Oct 24;7:380. doi: 10.3389/fphar.2016.00380. eCollection 2016. Front Pharmacol. 2016. PMID: 27822185 Free PMC article.
Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin.
Manna R, Cauda R, Feriozzi S, Gambaro G, Gasbarrini A, Lacombe D, Livneh A, Martini A, Ozdogan H, Pisani A, Riccio E, Verrecchia E, Dagna L; International Panel for RAre recurrent FUO-IPRAFUO. Manna R, et al. Intern Emerg Med. 2017 Oct;12(7):1059-1067. doi: 10.1007/s11739-017-1704-y. Epub 2017 Jul 19. Intern Emerg Med. 2017. PMID: 28726033
311 results